Company
Intelliatx
To transform the lives of people with severe diseases by developing and commercializing potentially curative treatments.
Also known as Intellia Therapeutics, Intellia Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Intellia Therapeutics, Inc.
- intelliatx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Intellia, we are aiming to revolutionize medicine by leveraging CRISPR gene editing and other core technologies to durably treat the root causes of disease.
Funding snapshot
- Total raised
- $70MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $70M2015-08-20
Funding rounds
- Round, 2015
- $70M2015-08-20, SEC form D sold, 28 investors
Loading relationship preview